Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Revium Rx Reports 28% Decrease in Net Loss for Q2 2026
Revium Rx Reports Q1 2026 Financial Results with $725K Net Loss and Increased R&D Expenses
Revium Rx Reports $13.4 Million Net Loss and Focus Shift Following LipoVation Acquisition